FDA Inspection
Acella Pharmaceuticals, LLCAcella Pharmaceuticals, LLC – FDA Inspection, Jan 7, 2020
Record Details
This FDA Inspection record concerns Acella Pharmaceuticals, LLC, with an inspection on January 7, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Acella Pharmaceuticals, LLC
- Inspection Date
- January 7, 2020
- Product Type
- Drugs
View Company Profile
ID · 6b594528-6f59-4fe3-b0ed-1b0264f258f7
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1115488
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Warning Letter
Other FDA inspections of Acella Pharmaceuticals, LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| December 18, 2024 | VAI | Atlanta District Office | Postmarketing Surveillance and Epidemiology: Human Drugs |
| February 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 28, 2015 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| September 10, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Acella Pharmaceuticals, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.